Taken together, these issues suggest that the observed links between elevated Lp(a), lipoprotein dysfunction, and AF should be viewed as provisional and confirmed in large, multi-ethnic prospective cohorts using standardized assays and rigorous AF phenotyping. The gene discussed is LPA; the disease is atrial fibrillation.